Likewise, the lower anandamide and overall NAEs levels observed in the melanoma was not changed by JZL184 treatment, indicating that the biosynthesis of NAEs via N-acyl phosphatidylethanolamine phospholipase D (NAPEPLD) rather than hydrolysis by CES1 could be involved [62, 63]. The gene discussed is NAPEPLD; the disease is melanoma.